Astrana Health, Inc. (NASDAQ:ASTH) Receives $53.29 Consensus Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $53.29.

ASTH has been the topic of a number of recent research reports. Truist Financial cut their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Stifel Nicolaus cut their target price on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Robert W. Baird cut their target price on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Barclays initiated coverage on Astrana Health in a research note on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price on the stock. Finally, Bank of America cut their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th.

Institutional Investors Weigh In On Astrana Health

Several institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Astrana Health by 4.5% during the first quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock valued at $151,918,000 after buying an additional 213,033 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Astrana Health by 10.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after acquiring an additional 101,192 shares during the period. 325 Capital LLC lifted its holdings in Astrana Health by 30.3% in the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after acquiring an additional 206,009 shares during the period. SteelPeak Wealth LLC lifted its holdings in Astrana Health by 4.8% in the first quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company's stock valued at $17,619,000 after acquiring an additional 26,192 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Astrana Health by 6.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company's stock valued at $15,490,000 after acquiring an additional 28,200 shares during the period. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Down 7.0%

ASTH stock traded down $1.89 during midday trading on Friday, hitting $25.19. The stock had a trading volume of 301,263 shares, compared to its average volume of 289,062. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The business has a 50-day moving average of $30.62 and a two-hundred day moving average of $34.84. Astrana Health has a 52-week low of $23.12 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). The firm had revenue of $620.39 million during the quarter, compared to analysts' expectations of $628.11 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Astrana Health's revenue for the quarter was up 53.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.31 earnings per share. As a group, equities research analysts forecast that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.